These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 18632739)

  • 1. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
    Dickerson BC; Bakkour A; Salat DH; Feczko E; Pacheco J; Greve DN; Grodstein F; Wright CI; Blacker D; Rosas HD; Sperling RA; Atri A; Growdon JH; Hyman BT; Morris JC; Fischl B; Buckner RL
    Cereb Cortex; 2009 Mar; 19(3):497-510. PubMed ID: 18632739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
    Bakkour A; Morris JC; Dickerson BC
    Neurology; 2009 Mar; 72(12):1048-55. PubMed ID: 19109536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.
    d'Oleire Uquillas F; Jacobs HIL; Hanseeuw B; Marshall GA; Properzi M; Schultz AP; LaPoint MR; Johnson KA; Sperling RA; Vannini P
    Neuroimage Clin; 2018; 17():388-396. PubMed ID: 29159051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease.
    Potter PE; Rauschkolb PK; Pandya Y; Sue LI; Sabbagh MN; Walker DG; Beach TG
    Acta Neuropathol; 2011 Jul; 122(1):49-60. PubMed ID: 21533854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
    Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
    Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.
    Dickerson BC; Stoub TR; Shah RC; Sperling RA; Killiany RJ; Albert MS; Hyman BT; Blacker D; Detoledo-Morrell L
    Neurology; 2011 Apr; 76(16):1395-402. PubMed ID: 21490323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology.
    Tuzzi E; Balla DZ; Loureiro JRA; Neumann M; Laske C; Pohmann R; Preische O; Scheffler K; Hagberg GE
    J Alzheimers Dis; 2020; 73(4):1481-1499. PubMed ID: 31958079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical thickness in relation to clinical symptom onset in preclinical AD.
    Pettigrew C; Soldan A; Zhu Y; Wang MC; Moghekar A; Brown T; Miller M; Albert M;
    Neuroimage Clin; 2016; 12():116-22. PubMed ID: 27408796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity.
    Park JE; Yun J; Kim SJ; Shim WH; Oh JS; Oh M; Roh JH; Seo SW; Oh SJ; Kim JS
    PLoS One; 2019; 14(12):e0226265. PubMed ID: 31834916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in cortical thickness with dementia severity in Alzheimer's disease.
    Im K; Lee JM; Seo SW; Yoon U; Kim ST; Kim YH; Kim SI; Na DL
    Neurosci Lett; 2008 May; 436(2):227-31. PubMed ID: 18400396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition.
    Bakkour A; Morris JC; Wolk DA; Dickerson BC
    Neuroimage; 2013 Aug; 76():332-44. PubMed ID: 23507382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.
    Putcha D; Brickhouse M; O'Keefe K; Sullivan C; Rentz D; Marshall G; Dickerson B; Sperling R
    J Neurosci; 2011 Nov; 31(48):17680-8. PubMed ID: 22131428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.
    Marshall GA; Lorius N; Locascio JJ; Hyman BT; Rentz DM; Johnson KA; Sperling RA
    J Alzheimers Dis; 2014; 41(3):719-28. PubMed ID: 24685624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Richards BA; Chertkow H; Singh V; Robillard A; Massoud F; Evans AC; Kabani NJ
    Neurobiol Aging; 2009 Oct; 30(10):1626-36. PubMed ID: 18261828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden.
    Drzezga A; Becker JA; Van Dijk KR; Sreenivasan A; Talukdar T; Sullivan C; Schultz AP; Sepulcre J; Putcha D; Greve D; Johnson KA; Sperling RA
    Brain; 2011 Jun; 134(Pt 6):1635-46. PubMed ID: 21490054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging.
    Tosun D; Mojabi P; Weiner MW; Schuff N
    Neuroimage; 2010 Aug; 52(1):186-97. PubMed ID: 20406691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dynamics of cortical and hippocampal atrophy in Alzheimer disease.
    Sabuncu MR; Desikan RS; Sepulcre J; Yeo BT; Liu H; Schmansky NJ; Reuter M; Weiner MW; Buckner RL; Sperling RA; Fischl B;
    Arch Neurol; 2011 Aug; 68(8):1040-8. PubMed ID: 21825241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.